Stereotaxis: Here’s What Investors Need to Know Before Earnings

Stereotaxis (NASDAQ:STXS) will report earnings after markets close on Monday, May 13th. Stereotaxis Inc. designs, manufactures and markets advanced cardiology instrument control system for use in the cath lab that is used in the treatment of coronary artery disease and arrhythmias. The company markets Stereotaxis System in the United States and Europe.

Here is your Cheat Sheet to Stereotaxis Earnings:

Earnings Expectations: Analysts expect earnings of $-0.50 per share on revenues of $12.00 million.

Analyst Trends:

Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a loss of $0.29 to a loss $0.53. For the current year, the average estimate is a loss of $1.8, which is better than the estimate ninety days ago.

Earnings Trends:

Here’s how Stereotaxis has been performing on an annual basis:

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in millions 40.37 51.15 54.05 41.99 46.56
Diluted EPS ($) -12.00 -6.30 -3.94 -5.84 -1.33

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Dec. 31, 2011 Mar. 31, 2012 Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012
Revenue ($) in millions 11.62 12.28 10.51 11.56 12.20
Diluted EPS ($) -1.004 -1.10 0.32 -0.25 -0.5516

Past Performance:
Stereotaxis has beat analyst estimates 2 times in the past four quarters. This is not consistent enough to get bullish yet.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at]